RxDoctor Payments Data

Janet Weir

Allergy & Immunology · Tacoma, WANPI 1447250824

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Optinose US, Inc. at 51.9% of the total. Reporting peaked in 2019 at $3,787 and has fallen 99.0% since, to $38 in 2025.

$6,358in general payments, 2019–2025

Across 146 payments — averaging $43.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$3K
  • GSK$1K
  • AstraZeneca$604
  • Biocryst US Sales Co., LLC$292
  • CSL Behring$275
  • Sanofi$125
  • plus $744 from 15 others

What the payments were for

  • Consulting fees$2,50039%
  • Travel & lodging$63010%
  • Food & beverage$3,22851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,358 in reported general payments places this provider in the 70th percentile of 81 allergy & immunology providers in Washington.

See all allergy & immunology providers in Washington

Other allergy & immunology in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →